# Giapreza

NDC: 68547-005
Generic name: angiotensin II
Labeler / Manufacturer: La Jolla Pharmaceutical Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220915

FDA application: NDA209360

## Active ingredients

- ANGIOTENSIN II: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68547-005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68547-005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c265d69a-3efe-4107-9a9e-e6fd3d531c48